Raymond James Financial Services Advisors’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,845
Closed -$22K 3423
2024
Q1
$22K Buy
1,845
+95
+5% +$810 ﹤0.01% 3338
2023
Q4
$7.04K Hold
1,750
﹤0.01% 3273
2023
Q3
$4.79K Sell
1,750
-100
-5% -$467 ﹤0.01% 3249
2023
Q2
$12.4K Buy
1,850
+100
+6% +$607 ﹤0.01% 3204
2023
Q1
$11.2K Hold
1,750
﹤0.01% 3218
2022
Q4
$4.32K Hold
1,750
﹤0.01% 3225
2022
Q3
$4K Hold
1,750
﹤0.01% 3233
2022
Q2
$5K Hold
1,750
﹤0.01% 3228
2022
Q1
$6K Hold
1,750
﹤0.01% 3304
2021
Q4
$7K Hold
1,750
﹤0.01% 3278
2021
Q3
$11K Sell
1,750
-700
-29% -$4.77K ﹤0.01% 3257
2021
Q2
$20K Buy
2,450
+200
+9% +$1.75K ﹤0.01% 3252
2021
Q1
$25K Buy
2,250
+180
+9% +$2.72K ﹤0.01% 3131
2020
Q4
$9K Sell
2,070
-180
-8% -$795 ﹤0.01% 2973
2020
Q3
$13K Hold
2,250
﹤0.01% 2840
2020
Q2
$12K Buy
2,250
+300
+15% +$1.93K ﹤0.01% 2783
2020
Q1
$10K Buy
1,950
+50
+3% +$378 ﹤0.01% 2391
2019
Q4
$12K Buy
1,900
+150
+9% +$658 ﹤0.01% 2821
2019
Q3
$6K Hold
1,750
﹤0.01% 2788
2019
Q2
$7K Hold
1,750
﹤0.01% 2826
2019
Q1
$6K Hold
1,750
﹤0.01% 2781
2018
Q4
$5K Hold
1,750
﹤0.01% 2552
2018
Q3
$9K Sell
1,750
-1,250
-42% -$6.96K ﹤0.01% 2790
2018
Q2
$14K Hold
3,000
﹤0.01% 2737
2018
Q1
$13K Hold
3,000
﹤0.01% 2522
2017
Q4
$12K Hold
3,000
﹤0.01% 2517
2017
Q3
$15K Sell
3,000
-304
-9% -$1.71K ﹤0.01% 2528
2017
Q2
$21K Hold
3,304
﹤0.01% 2463
2017
Q1
$19K Buy
3,304
+304
+10% +$1.78K ﹤0.01% 2376
2016
Q4
$17K Hold
3,000
﹤0.01% 2299
2016
Q3
$22K Hold
3,000
﹤0.01% 2245
2016
Q2
$26K Hold
3,000
﹤0.01% 2206
2016
Q1
$27K Buy
+3,000
New +$23.6K ﹤0.01% 2005

Other funds holding CATX